Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Jose Maria Zuazo Morquecho

Jose Maria Zuazo Morquecho

Institutions of which they are part

Liver Diseases
Vall Hebron Institut de Recerca
Jose Maria Zuazo Morquecho

Jose Maria Zuazo Morquecho

Jose Maria Zuazo Morquecho

Institutions of which they are part

Liver Diseases
Vall Hebron Institut de Recerca

Related news

Dr. Raul Herance

We develop a method to diagnose fatty liver in a quantitative and non-invasive way

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

Grup de Malalties Hepàtiques del VHIR

A clinical trial has led to approval of the first drug for advanced fatty liver disease

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

Equip projecte ARTEMIs

We study fatty liver and cardiovascular complications with digital twins

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

See more

Related professionals

Mireia Benito Jimenez

Mireia Benito Jimenez

Research assistant
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Margot Noemi Costa Gutiérrez

Margot Noemi Costa Gutiérrez

Administrative
General Services and Infrastructures Unit
Manager
Read more
Yasmine Margaret Baktash

Yasmine Margaret Baktash

Postdoctoral researcher
Infectious Diseases
Read more
Elba Agusti Rovira

Elba Agusti Rovira

Research technician
Donation and transplantation of organs, tissues and cells
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.